Amundi »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Amundi

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Amundi

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1k 3.1M 0.00

More positions owned by Amundi

NVIDIA Corporation (NVDA)
Totalenergies Se Act (TTE)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Astrazeneca Ord (AZN)
Costco Wholesale Corporation (COST)

View all positions for Amundi

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1